[HTML][HTML] PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance

RN Kulkarni, US Jhala, JN Winnay… - The Journal of …, 2004 - Am Soc Clin Investig
RN Kulkarni, US Jhala, JN Winnay, S Krajewski, M Montminy, CR Kahn
The Journal of clinical investigation, 2004Am Soc Clin Investig
Inadequate compensatory β cell hyperplasia in insulin-resistant states triggers the
development of overt diabetes. The mechanisms that underlie this crucial adaptive response
are not fully defined. Here we show that the compensatory islet-growth response to insulin
resistance in 2 models—insulin receptor (IR)/IR substrate–1 (IRS-1) double heterozygous
mice and liver-specific IR KO (LIRKO) mice—is severely restricted by PDX-1 heterozygosity.
Six-month-old IR/IRS-1 and LIRKO mice both showed up to a 10-fold increase in β cell …
Inadequate compensatory β cell hyperplasia in insulin-resistant states triggers the development of overt diabetes. The mechanisms that underlie this crucial adaptive response are not fully defined. Here we show that the compensatory islet-growth response to insulin resistance in 2 models — insulin receptor (IR)/IR substrate–1 (IRS-1) double heterozygous mice and liver-specific IR KO (LIRKO) mice — is severely restricted by PDX-1 heterozygosity. Six-month-old IR/IRS-1 and LIRKO mice both showed up to a 10-fold increase in β cell mass, which involved epithelial-to-mesenchymal transition. In both models, superimposition of PDX-1 haploinsufficiency upon the background of insulin resistance completely abrogated the adaptive islet hyperplastic response, and instead the β cells showed apoptosis resulting in premature death of the mice. This study shows that, in postdevelopmental states of β cell growth, PDX-1 is a critical regulator of β cell replication and is required for the compensatory response to insulin resistance.
The Journal of Clinical Investigation